New drug interaction study launches in healthy volunteers

NCT ID NCT07343245

Recruiting now Knowledge-focused Sponsor: Daewon Pharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial is testing how an experimental drug called DW4421 interacts with three different NSAIDs (common pain relievers like ibuprofen). The study involves 150 healthy adults aged 19 to 50. Researchers will measure safety and how the drugs move through the body to understand potential interactions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DW4421 (an experimental drug) and three different NSAIDs (common pain relievers)
What this could lead to: If successful, this study will show whether DW4421 can be safely taken with common pain relievers, guiding future trials for potential treatments.
What could go wrong: This is an early Phase 1 trial in healthy volunteers, not patients. It only measures safety and drug levels, not effectiveness. Results may not predict real-world use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY ADULT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY ADULT

Contacts and locations

Locations

Chungbuk National University Hospital
RECRUITING

Cheongju-si, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.